Evaluation of a 74-kDa transferrin-binding protein from Moraxella (Branhamella) catarrhalis as a vaccine candidate

D Chen1, J C McMichael, K R VanDerMeid

  • 1Wyeth-Lederle Vaccines, New York, NY 14586-9728, USA.

Vaccine
|September 29, 1999
PubMed

Insights

A 74-kDa outer membrane protein from Moraxella catarrhalis shows promise as a vaccine candidate due to conserved surface epitopes. However, variability in antibody responses and protective efficacy requires further investigation.

Area of Science:

  • Microbiology
  • Immunology
  • Vaccine Development

Background:

  • Moraxella catarrhalis is a significant respiratory pathogen.
  • Outer membrane proteins are key targets for vaccine development against bacterial infections.

Purpose of the Study:

  • To evaluate a 74-kDa outer membrane protein of Moraxella catarrhalis as a potential vaccine candidate.
  • To assess the immunogenicity and protective efficacy of the 74-kDa protein in preclinical models.

Main Methods:

  • Isolation and characterization of a 74-kDa outer membrane protein.
  • Immunization of mice with the isolated protein.
  • Assessment of antibody responses, including complement-dependent bactericidal activity.
  • Evaluation of bacterial clearance in a murine pulmonary infection model.

Main Results:

  • The 74-kDa protein binds transferrin and has conserved, surface-exposed epitopes.
  • Immunization elicited complement-dependent bactericidal antibodies in mice, but with strain-specific cross-reactivity.
  • Serotypic divergence impacted antibody efficacy and bacterial clearance in a murine model.
  • Human antibodies reactive with the protein lacked bactericidal activity.

Conclusions:

  • The 74-kDa outer membrane protein is a potential vaccine candidate for Moraxella catarrhalis.
  • Antigenic variability and the protective capacity of elicited antibodies need further study.
  • Understanding immune responses is crucial for developing effective vaccines against this pathogen.

Related Concept Videos